메뉴 건너뛰기




Volumn 74, Issue 2, 2011, Pages 143-146

Antiangiogenic drugs and advanced proliferative diabetic retinopathy

Author keywords

Anti angiogenic drugs; Diabetic retinopathy; Retinal detachment; Vitrectomy; Vitreous hemorrhage

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

EID: 79961114947     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492011000200017     Document Type: Article
Times cited : (11)

References (40)
  • 1
    • 0033005587 scopus 로고    scopus 로고
    • Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group
    • rd, Davis MD, Chew EY. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol. 1999;127(2):137-41.
    • (1999) Am J Ophthalmol , vol.127 , Issue.2 , pp. 137-141
    • Fong, D.S.1    Ferris 3rd, F.L.2    Davis, M.D.3    Chew, E.Y.4
  • 2
    • 0023236957 scopus 로고
    • Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy
    • Aaberg TM, Abrams GW. Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy. Ophthalmology. 1987;94(7):775-9.
    • (1987) Ophthalmology , vol.94 , Issue.7 , pp. 775-779
    • Aaberg, T.M.1    Abrams, G.W.2
  • 3
    • 58249102934 scopus 로고    scopus 로고
    • Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy
    • Ishikawa K, Honda S, Tsukahara Y, Negi A. Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy. Eye (Lond). 2009; 23(1):108-11.
    • (2009) Eye (Lond) , vol.23 , Issue.1 , pp. 108-111
    • Ishikawa, K.1    Honda, S.2    Tsukahara, Y.3    Negi, A.4
  • 4
    • 0021843911 scopus 로고
    • Thrombin infusion for the control of intraocular bleeding during vitreous surgery
    • de Bustros S, Glaser BM, Johnson MA. Thrombin infusion for the control of intraocular bleeding during vitreous surgery. Arch Ophthalmol. 1985;103(6):837-9.
    • (1985) Arch Ophthalmol , vol.103 , Issue.6 , pp. 837-839
    • de Bustros, S.1    Glaser, B.M.2    Johnson, M.A.3
  • 5
    • 0023140305 scopus 로고
    • Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula
    • Thompson JT, de Bustros S, Michels RG, Rice TA. Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula. Arch Ophthalmol. 1987;105(4): 497-502.
    • (1987) Arch Ophthalmol , vol.105 , Issue.4 , pp. 497-502
    • Thompson, J.T.1    de Bustros, S.2    Michels, R.G.3    Rice, T.A.4
  • 7
    • 33749631288 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study)
    • Jorge R, Costa RA, Calucci D, Cintra LP, Scott IU. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina. 2006;26(9): 1006-13.
    • (2006) Retina , vol.26 , Issue.9 , pp. 1006-1013
    • Jorge, R.1    Costa, R.A.2    Calucci, D.3    Cintra, L.P.4    Scott, I.U.5
  • 9
    • 33751008601 scopus 로고    scopus 로고
    • [VEGF as an angiogenic, neurotrophic, and neuroprotective factor]
    • Review. Polish
    • Namiecinska M, Marciniak K, Nowak JZ. [VEGF as an angiogenic, neurotrophic, and neuroprotective factor]. Postepy Hig Med Dosw (Online). 2005;59:573-83. Review. Polish.
    • (2005) Postepy Hig Med Dosw (Online) , vol.59 , pp. 573-583
    • Namiecinska, M.1    Marciniak, K.2    Nowak, J.Z.3
  • 10
    • 70350469069 scopus 로고    scopus 로고
    • Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy
    • González VH, Giuliari GP, Banda RM, Guel DA. Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy. Br J Ophthalmol. 2009;93(11):1474-8.
    • (2009) Br J Ophthalmol , vol.93 , Issue.11 , pp. 1474-1478
    • González, V.H.1    Giuliari, G.P.2    Banda, R.M.3    Guel, D.A.4
  • 11
    • 33646464279 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage
    • Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 2006;26(3):275-8.
    • (2006) Retina , vol.26 , Issue.3 , pp. 275-278
    • Spaide, R.F.1    Fisher, Y.L.2
  • 12
    • 33745392312 scopus 로고    scopus 로고
    • Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy
    • Oshima Y, Sakaguchi H, Gomi F, Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2006;142(1):155-8.
    • (2006) Am J Ophthalmol , vol.142 , Issue.1 , pp. 155-158
    • Oshima, Y.1    Sakaguchi, H.2    Gomi, F.3    Tano, Y.4
  • 13
    • 33746290475 scopus 로고    scopus 로고
    • Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma
    • Silva Paula J, Jorge R, Alves Costa R, Rodrigues Mde L, Scott IU. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand. 2006;84(4):556-7.
    • (2006) Acta Ophthalmol Scand , vol.84 , Issue.4 , pp. 556-557
    • Silva Paula, J.1    Jorge, R.2    Alves Costa, R.3    Rodrigues Mde, L.4    Scott, I.U.5
  • 14
    • 47649090159 scopus 로고    scopus 로고
    • Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study)
    • Tonello M, Costa RA, Almeida FP, Barbosa JC, Scott IU, Jorge R. Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol. 2008;86(4):385-9.
    • (2008) Acta Ophthalmol , vol.86 , Issue.4 , pp. 385-389
    • Tonello, M.1    Costa, R.A.2    Almeida, F.P.3    Barbosa, J.C.4    Scott, I.U.5    Jorge, R.6
  • 15
    • 65349135042 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy
    • rd, Yunker JJ, Vail R, McGwin G Jr. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy. Retina. 2008;28(9):1319-24.
    • (2008) Retina , vol.28 , Issue.9 , pp. 1319-1324
    • Mason 3rd, J.O.1    Yunker, J.J.2    Vail, R.3    McGwin Jr., G.4
  • 16
    • 66149129948 scopus 로고    scopus 로고
    • Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy
    • Cho WB, Oh SB, Moon JW, Kim HC. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy. Retina. 2009;29(4):516-22.
    • (2009) Retina , vol.29 , Issue.4 , pp. 516-522
    • Cho, W.B.1    Oh, S.B.2    Moon, J.W.3    Kim, H.C.4
  • 17
    • 79961113592 scopus 로고    scopus 로고
    • Descending doses of intravitreal bevacizumab for the regression of diabetic neovascularization
    • Oct 23. [Epub ahead of print]
    • Stergiou PK, Symeonidis C, Dimitrakos SA. Descending doses of intravitreal bevacizumab for the regression of diabetic neovascularization. Acta Ophthalmol. 2009 Oct 23. [Epub ahead of print]
    • (2009) Acta Ophthalmol
    • Stergiou, P.K.1    Symeonidis, C.2    Dimitrakos, S.A.3
  • 19
    • 70349440840 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial
    • Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology. 2009;116(10):1943-8.
    • (2009) Ophthalmology , vol.116 , Issue.10 , pp. 1943-1948
    • Ahmadieh, H.1    Shoeibi, N.2    Entezari, M.3    Monshizadeh, R.4
  • 20
    • 77954527576 scopus 로고    scopus 로고
    • Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy
    • El-Batarny AM. Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy. Clin Ophthalmol. 2008;2(4):709-16.
    • (2008) Clin Ophthalmol , vol.2 , Issue.4 , pp. 709-716
    • El-Batarny, A.M.1
  • 21
    • 68249091059 scopus 로고    scopus 로고
    • Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin)
    • Lo WR, Kim SJ, Aaberg TM Sr, Bergstrom C, Srivastava SK, Yan J, et al. Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin). Retina. 2009;29(7):926-31.
    • (2009) Retina , vol.29 , Issue.7 , pp. 926-931
    • Lo, W.R.1    Kim, S.J.2    Aaberg Sr., T.M.3    Bergstrom, C.4    Srivastava, S.K.5    Yan, J.6
  • 22
    • 67749147367 scopus 로고    scopus 로고
    • Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy
    • Yeh PT, Yang CM, Lin YC, Chen MS, Yang CH. Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy. Retina. 2009;29(6):768-74.
    • (2009) Retina , vol.29 , Issue.6 , pp. 768-774
    • Yeh, P.T.1    Yang, C.M.2    Lin, Y.C.3    Chen, M.S.4    Yang, C.H.5
  • 23
    • 77956214919 scopus 로고    scopus 로고
    • Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment
    • Yeung L, Liu L, Wu WC, Kuo YH, Chao AN, Chen KJ, et al. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment. Acta Ophthalmol. 2010;88(6): 635-40.
    • (2010) Acta Ophthalmol , vol.88 , Issue.6 , pp. 635-640
    • Yeung, L.1    Liu, L.2    Wu, W.C.3    Kuo, Y.H.4    Chao, A.N.5    Chen, K.J.6
  • 24
    • 67349285875 scopus 로고    scopus 로고
    • Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment
    • Oshima Y, Shima C, Wakabayashi T, Kusaka S, Shiraga F, Ohji M, Tano Y. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology. 2009;116(5):927-38.
    • (2009) Ophthalmology , vol.116 , Issue.5 , pp. 927-938
    • Oshima, Y.1    Shima, C.2    Wakabayashi, T.3    Kusaka, S.4    Shiraga, F.5    Ohji, M.6    Tano, Y.7
  • 25
    • 66149143624 scopus 로고    scopus 로고
    • Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study)
    • da R Lucena D, Ribeiro JA, Costa RA, Barbosa JC, Scott IU, de Figueiredo-Pontes LL, Jorge R. Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study). Br J Ophthalmol. 2009;93(5):688-91.
    • (2009) Br J Ophthalmol , vol.93 , Issue.5 , pp. 688-691
    • da Lucena, D.R.1    Ribeiro, J.A.2    Costa, R.A.3    Barbosa, J.C.4    Scott, I.U.5    de Figueiredo-Pontes, L.L.6    Jorge, R.7
  • 26
    • 69049096319 scopus 로고    scopus 로고
    • Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?
    • Comment in: Eye (Lond). 2010;24(2):388; author reply 389
    • Romano MR, Gibran SK, Marticorena J, Wong D, Heimann H. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage? Eye (Lond). 2009;23(8):1698-701. Comment in: Eye (Lond). 2010;24(2):388; author reply 389.
    • (2009) Eye (Lond) , vol.23 , Issue.8 , pp. 1698-1701
    • Romano, M.R.1    Gibran, S.K.2    Marticorena, J.3    Wong, D.4    Heimann, H.5
  • 27
    • 50849109818 scopus 로고    scopus 로고
    • Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series
    • Yeoh J, Williams C, Allen P, Buttery R, Chiu D, Clark B, et al. Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series. Clin Experiment Ophthalmol. 2008;36(5):449-54.
    • (2008) Clin Experiment Ophthalmol , vol.36 , Issue.5 , pp. 449-454
    • Yeoh, J.1    Williams, C.2    Allen, P.3    Buttery, R.4    Chiu, D.5    Clark, B.6
  • 28
    • 47549105882 scopus 로고    scopus 로고
    • Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy
    • Yang CM, Yeh PT, Yang CH, Chen MS. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol. 2008;146(2):211-7.
    • (2008) Am J Ophthalmol , vol.146 , Issue.2 , pp. 211-217
    • Yang, C.M.1    Yeh, P.T.2    Yang, C.H.3    Chen, M.S.4
  • 29
    • 43549104713 scopus 로고    scopus 로고
    • Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)
    • Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, Williams G. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol. 2008;246(6):837-42.
    • (2008) Graefes Arch Clin Exp Ophthalmol , vol.246 , Issue.6 , pp. 837-842
    • Rizzo, S.1    Genovesi-Ebert, F.2    Di Bartolo, E.3    Vento, A.4    Miniaci, S.5    Williams, G.6
  • 30
    • 33747335983 scopus 로고    scopus 로고
    • Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy
    • Chen E, Park CH. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina. 2006;26(6): 699-700.
    • (2006) Retina , vol.26 , Issue.6 , pp. 699-700
    • Chen, E.1    Park, C.H.2
  • 31
    • 53649110758 scopus 로고    scopus 로고
    • Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma
    • Miki A, Oshima Y, Otori Y, Kamei M, Tano Y. Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma. Br J Ophthalmol. 2008;92(10):1431-3.
    • (2008) Br J Ophthalmol , vol.92 , Issue.10 , pp. 1431-1433
    • Miki, A.1    Oshima, Y.2    Otori, Y.3    Kamei, M.4    Tano, Y.5
  • 32
    • 70349473580 scopus 로고    scopus 로고
    • Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage?
    • Romano MR, Gibran SK, Marticorena J, Wong D, Heimann H. Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage? Eur J Ophthalmol. 2009;19(4):618-21.
    • (2009) Eur J Ophthalmol , vol.19 , Issue.4 , pp. 618-621
    • Romano, M.R.1    Gibran, S.K.2    Marticorena, J.3    Wong, D.4    Heimann, H.5
  • 33
    • 35349022642 scopus 로고    scopus 로고
    • Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy
    • Sawada O, Kawamura H, Kakinoki M, Sawada T, Ohji M. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy. Arch Ophthalmol. 2007;125(10):1363-6.
    • (2007) Arch Ophthalmol , vol.125 , Issue.10 , pp. 1363-1366
    • Sawada, O.1    Kawamura, H.2    Kakinoki, M.3    Sawada, T.4    Ohji, M.5
  • 35
    • 68149153131 scopus 로고    scopus 로고
    • Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (avastin) with pars plana vitrectomy
    • Lee SJ, Koh HJ. Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (avastin) with pars plana vitrectomy. J Ocul Pharmacol Ther. 2009;25(2):173-4.
    • (2009) J Ocul Pharmacol Ther , vol.25 , Issue.2 , pp. 173-174
    • Lee, S.J.1    Koh, H.J.2
  • 36
    • 67349141386 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study
    • 1030.e1-5
    • Bonini-Filho M, Costa RA, Calucci D, Jorge R, Melo LA Jr, Scott IU. Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study. Am J Ophthalmol. 2009;147(6):1022-30, 1030.e1-5.
    • (2009) Am J Ophthalmol , vol.147 , Issue.6 , pp. 1022-1030
    • Bonini-Filho, M.1    Costa, R.A.2    Calucci, D.3    Jorge, R.4    Melo Jr., L.A.5    Scott, I.U.6
  • 37
    • 62549148148 scopus 로고    scopus 로고
    • Bevacizumab (Avastin) as a surgical adjunct in diabetic vitrectomy for fibrovascular disease
    • Gandhi JS, Tan LT, Pearce I, Charles SJ. Bevacizumab (Avastin) as a surgical adjunct in diabetic vitrectomy for fibrovascular disease. Eye (Lond). 2009;23(3):742-3.
    • (2009) Eye (Lond) , vol.23 , Issue.3 , pp. 742-743
    • Gandhi, J.S.1    Tan, L.T.2    Pearce, I.3    Charles, S.J.4
  • 38
    • 55449117421 scopus 로고    scopus 로고
    • Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin) with pars plana vitrectomy
    • Lee CS, Koh HJ. Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin) with pars plana vitrectomy. Acta Ophthalmol. 2008; 86(7):812-3.
    • (2008) Acta Ophthalmol , vol.86 , Issue.7 , pp. 812-813
    • Lee, C.S.1    Koh, H.J.2
  • 39
    • 28344448202 scopus 로고    scopus 로고
    • Fibrinogen and ûbrin structure and functions
    • Mosesson MW. Fibrinogen and ûbrin structure and functions. J Thromb Haemost. 2005; 3(8):1894-904.
    • (2005) J Thromb Haemost , vol.3 , Issue.8 , pp. 1894-1904
    • Mosesson, M.W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.